Studies including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have demonstrated reduced cardiovascular events in patients with type 2 diabetes
The session on suicide risk will review the origins of the safety signal for suicidality and provide potential biologic explanations for the purported link with GLP-1 receptor agonists, Dr
Feel free to contact our team
Medications such as semaglutide and liraglutide have been noted to provide benefits, including improved glycemic control, weight loss, and a reduction in cardiovascular risk
Theyre easy to make, theyre easy to distribute, theyre easy to take, he says
We advise our patients to prioritize lean proteins, fiber, and whole foods and to avoid heavy, rich meals, especially in the beginning